RT @sitcancer: #JITC Research: Phase I study of samalizumab in chronic lymphocytic leukemia and multiple myeloma: blockade of the immune ch…
440 followers
46 followers
RT @sitcancer: #JITC Research: Phase I study of samalizumab in chronic lymphocytic leukemia and multiple myeloma: blockade of the immune ch…
19,289 followers
#JITC Research: Phase I study of samalizumab in chronic lymphocytic leukemia and multiple myeloma: blockade of the immune checkpoint CD200 https://t.co/toR2Tmf2tO https://t.co/hL6BoLMfOv
440 followers
RT @sitcancer: #JITC Research: Phase I study of samalizumab in chronic lymphocytic leukemia and multiple myeloma: blockade of the immune ch…